The ASSET Program for Youth With ASD

计划入组 85 人 · 首次发布于 2024 年 8 月 2 日

STRIVE Post-Market Registry Study

计划入组 150 人 · 首次发布于 2020 年 3 月 10 日

The STRIVE Before Surgery Trial

计划入组 902 人 · 首次发布于 2024 年 7 月 19 日

LLC-0424

Pain management program (Hana Pharm)

VPM-5001

Topicare Management LLC

United States

Strive Pharmaceuticals Inc

United States

USA HealthCare Management, LLC

United States

Strive Completes $225 Million Follow-On Offering, Rapidly Retires 92% of Semler Scientific Debt

MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases

Acelyrin's Izokibep Advances in Phase 3 Trials Amidst Analyst Revisions and Institutional Investment